Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Most Undervalued Foreign Stocks to Buy Now

In this piece we will look at the 5 Most Undervalued Foreign Stocks to Buy Now. Please visit 9 Most Undervalued Foreign Stocks to Buy Now if you’d like to see an extended list and how we came up with the list of Most Undervalued Foreign Stocks to Buy Now.

5. UBS Group AG (NYSE:UBS)

Forward Price to Earnings Ratio: 13.98

Number of Hedge Fund Holders: 39

UBS Group AG (NYSE:UBS) is one of the Most Undervalued Foreign Stocks to Buy Now. On May 15, the Federal Reserve Board announced that it has formally ended its enforcement actions against UBS and its acquired subsidiary Credit Suisse, marking the close of a regulatory saga that began in 2023.

According to a report by Bloomberg, the actions had been triggered by serious failures in counterparty credit-risk management at Credit Suisse, specifically in its dealings with collapsed hedge fund Archegos Capital Management. When Archegos imploded in March 2021, Credit Suisse was by far the hardest hit among affected banks, suffering losses of around CHF 5 billion. This became a central factor in Credit Suisse’s broader crisis, which eventually led to its emergency takeover by UBS in 2023.

The report noted that the Fed had imposed fines totaling roughly $387 million and mandated improvements in supervision, liquidity, and data management. The UK’s Prudential Regulation Authority fined the bank £87 million, while Switzerland’s FINMA required corrective measures.

UBS has met those obligations and the Fed’s termination of the orders indicates that regulators are satisfied with the remediation work carried out. Bloomberg noted that this allows UBS Group AG (NYSE:UBS) to move forward with fewer legacy regulatory burdens hanging over its integration.

​UBS Group AG (NYSE:UBS) is a global financial institution that provides wealth management, personal and corporate banking, asset management, and investment banking services to private, institutional, and corporate clients worldwide.

4. British American Tobacco p.l.c. (NYSE:BTI)

Forward Price to Earnings Ratio: 13.28

Number of Hedge Fund Holders: 40

British American Tobacco p.l.c. (NYSE:BTI) is one of the Most Undervalued Foreign Stocks to Buy Now. On May 19, the company announced opening a new Information, Digital and Technology hub in Bengaluru, India. Management noted that this step is part of the company’s strategy to become a more agile and data driven business.

Notably, the hub centers around the company’s Future Capabilities Centre, which is designed to consolidate key technology functions under one roof and accelerate innovation across the group.  Moreover, the hub will bring together teams working across Cyber Security, Data & Analytics, Artificial Intelligence, and Digital Platforms. These teams will collaborate with strategic partners to drive continuous improvement.

British American Tobacco p.l.c. (NYSE:BTI) noted that the choice of Bengaluru is deliberate as it is widely regarded as India’s premier technology ecosystem. The announcement indicates that BAT is increasingly embedding technology at the core of its operations, rather than treating it as a peripheral function.

British American Tobacco (NYSE:BTI) provides tobacco and nicotine products to consumers in the US, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa.

3. Shell plc (NYSE:SHEL)

Forward Price to Earnings Ratio: 7.98

Number of Hedge Fund Holders: 43

Shell plc (NYSE:SHEL) is one of the Most Undervalued Foreign Stocks to Buy Now. On May 18, HSBC analyst Kim Fustier upgraded Shell plc (NYSE:SHEL) from Hold to Buy and raised the price target from 3,350 GBp to 3,700 GBp. The analyst noted that two key factors drove the upgrade, including the firm’s upwards revision of cash flow estimates for the company and the recently completed ARC Resources deal has meaningfully improved Shell’s medium-term upstream growth visibility. The analyst noted that this gives investors greater clarity on future production and earnings.

Shell plc (NYSE:SHEL) reported its fiscal Q1 2026 earnings on May 7. According to a Reuters report published on the earnings day, the company’s first quarter adjusted earnings grew to $6.92 billion, beating analyst expectations of $6.36 billion. This was recognized as the highest quarterly profit in two years and was driven largely by gains linked to the Middle East war, which has pushed global energy prices sharply higher. Trading in its chemicals and products division was a standout, delivering $1.93 billion against expectations of just $1.24 billion.

The company also raised its dividend by 5%. However, the quarterly buyback was trimmed from $3.5 billion to $3 billion. Looking ahead, the company expects second quarter integrated gas production to fall by 36% due to the conflict’s ​impact.

Shell plc (NYSE:SHEL) is an integrated energy company with operations spanning exploration, production, refining, marketing, and chemical manufacturing, alongside growing investments in biofuels and hydrogen.

2. Novo Nordisk A/S (NYSE:NVO)

Forward Price to Earnings Ratio: 12.78

Number of Hedge Fund Holders: 55

Novo Nordisk A/S (NYSE:NVO) is one of the Most Undervalued Foreign Stocks to Buy Now. On May 6, Reuters reported that Novo Nordisk A/S (NYSE:NVO) topped first-quarter profit forecasts and also raised the full-year outlook slightly.

The results were driven by the company’s new Wegovy weight-loss pill, which was launched in the US in January. During the quarter the sales hit 2.26 billion Danish crowns, nearly double the analysts expectations. Moreover, the total prescriptions also topped the 2 million mark since its launch. The company calls this the strongest GLP-1 launch by volume in US history.

The adjusted operating profit for the quarter came in at 32.86 billion Danish crowns, and topped the expectation of 28.74 billion. Moreover, the group sales came in at 70.06 billion Danish, above the 69.07 billion ​expected by analysts. Looking ahead, Novo plans to expand the Wegovy pill beyond the US in the second half of 2026, with regulatory submissions already filed in Europe. The company forecasts full-year adjusted sales and operating profit to decline by 4% to 12%, better than the previously expected 5% to 13% decline.

Novo Nordisk (NYSE:NVO) is a drug manufacturer for global pharmaceutical products that operates through two segments: Obesity & Diabetes Care and Rare Disease. The company was founded in 1923 and is headquartered in Denmark.

1. PDD Holdings Inc. (NASDAQ:PDD)

Forward Price to Earnings Ratio: 7.93

Number of Hedge Fund Holders: 67

PDD Holdings Inc. (NASDAQ:PDD) is one of the Most Undervalued Foreign Stocks to Buy Now. On May 11, Reuters reported that Shein has accused PDD Holdings Inc. (NASDAQ:PDD)’s platform Temu of copyright infringement “on an industrial scale.” The company alleged that Temu used thousands of Shein’s product photos to advertise copycat clothing on its platform.

The report  noted that Shein’s lawyer described it as an attempt to gain an unfair advantage by piggybacking on a more established competitor. On the other hand, Temu in the trial that opened in London’s High Court denied the allegations and framed the lawsuit as a competitive tactic rather than a genuine intellectual property dispute.

Shein’s lawyer Benet ​Brandreth noted that Temu has dropped its defense against the copyright claims covering nearly 2,300 photos taken by Shein employees. ​Brandreth compared this to pleading guilty at the last moment. On the other hand Temu has filed a counter-claim, seeking damages after an earlier injunction forced it to remove thousands of product listings.

Separately, Temu alleges that Shein broke competition law by locking fast-fashion suppliers into exclusive agreements. This claim is expected to be heard at a separate trial next year.

That said, PDD Holdings Inc. (NASDAQ:PDD) is expected to release its fiscal first quarter 2026 earnings on May 27. The Street expects the company to post revenue around $16.08 billion, along with a GAAP EPS of $2.15.

PDD Holdings Inc. (NASDAQ:PDD) operates e-commerce platforms including Temu, offering a wide range of consumer products globally.

While we acknowledge the potential of PDD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PDD and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Best Stocks to Buy While the Market Is Down and 14 Stocks That Will Double in the Next 5 Years. 

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.